Life Times PE Ratio 2019-2023 | LTH
Current and historical p/e ratio for Life Times (LTH) from 2019 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Life Times PE ratio as of May 14, 2024 is 30.67.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Life Times PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-14 | 14.78 | 38.89 | |
| 2023-12-31 | 15.08 | $0.38 | 39.68 |
| 2023-09-30 | 15.21 | $0.33 | 46.09 |
| 2023-06-30 | 19.67 | $0.41 | 47.98 |
| 2023-03-31 | 15.96 | $0.32 | 49.88 |
| 2022-12-31 | 11.96 | $-0.02 | 0.00 |
| 2022-09-30 | 9.75 | $-1.73 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.927B | $2.217B |
| Life Time Group Holdings Inc. reshaped the way consumers approach their health through omnichannel, healthy way of life communities that address all aspects of healthy living, healthy aging and healthy entertainment. Life Time Group Holdings Inc. is based in CHANHASSEN, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.220B | 15.71 |
| Cencora (COR) | United States | $44.462B | 17.33 |
| ICON (ICLR) | Ireland | $25.533B | 24.10 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $16.499B | 24.29 |
| CochLear (CHEOY) | Australia | $14.039B | 0.00 |
| Viatris (VTRS) | United States | $13.526B | 4.04 |
| Revvity (RVTY) | United States | $13.024B | 22.85 |
| Natera (NTRA) | United States | $12.689B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.061B | 39.68 |
| Charles River Laboratories (CRL) | United States | $11.765B | 22.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.621B | 0.00 |
| Solventum (SOLV) | United States | $10.905B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| HealthEquity (HQY) | United States | $6.637B | 49.59 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Bausch + Lomb (BLCO) | Canada | $5.192B | 20.80 |
| Doximity (DOCS) | United States | $4.289B | 31.93 |
| PACS (PACS) | United States | $3.766B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.289B | 30.09 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| GoodRx Holdings (GDRX) | United States | $2.646B | 95.71 |
| Progyny (PGNY) | United States | $2.609B | 44.92 |
| Premier (PINC) | United States | $2.362B | 8.84 |
| AMN Healthcare Services Inc (AMN) | United States | $2.242B | 8.89 |
| Agilon Health (AGL) | United States | $2.143B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.111B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.935B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.926B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.546B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.323B | 0.00 |
| Embecta (EMBC) | United States | $0.818B | 5.56 |
| CareDx (CDNA) | United States | $0.780B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.718B | 7.62 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.655B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.611B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.433B | 43.20 |
| MultiPlan (MPLN) | United States | $0.412B | 0.00 |
| LifeMD (LFMD) | United States | $0.403B | 0.00 |
| ModivCare (MODV) | United States | $0.378B | 7.08 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| DocGo (DCGO) | United States | $0.329B | 17.56 |
| Sera Prognostics (SERA) | United States | $0.295B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.257B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.74 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |